Ring Mountain Capital’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.31M Buy
511,105
+57,025
+13% +$394K 1.81% 14
2025
Q4
$3.73M Buy
454,080
+59,216
+15% +$381K 1.91% 13
2025
Q3
$1.93M Buy
394,864
+36,444
+10% +$186K 1.07% 20
2025
Q2
$2.02M Buy
358,420
+51,463
+17% +$272K 1.23% 18
2025
Q1
$1.79M Buy
306,957
+29,098
+10% +$201K 1.34% 19
2024
Q4
$2.09M Buy
+277,859
New +$2.13M 1.4% 17

Other funds holding PROF

Ring Mountain Capital's PROF Position: Q1 2026 in Review

Ring Mountain Capital increased its Profound Medical (PROF) stake by 13% in Q1 2026, buying an estimated $394K and bringing the position to 511,105 shares worth $3.31M. The position accounts for 1.81% of the portfolio, ranked #14.

Ring Mountain Capital first reported a position in PROF in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.73M in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Ring Mountain Capital held 511,105 shares of Profound Medical worth $3.31M as of Q1 2026.
  • Ring Mountain Capital bought 57,025 Profound Medical shares in Q1 2026, an estimated $394K.
  • Profound Medical made up 1.81% of Ring Mountain Capital's portfolio in Q1 2026, its #14 holding.
  • Ring Mountain Capital first reported a position in Profound Medical in Q4 2024 and has held it in 6 quarters since.
  • Ring Mountain Capital's Profound Medical position peaked at $3.73M in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Ring Mountain Capital's 13F filing for Q1 2026, filed 1 May 2026.